# IDEXX LABORATORIES INC /DE (IDXX) FY2025 Q1 Balance Sheet

- Company: IDEXX LABORATORIES INC /DE (IDXX)
- Period: As of 2025-03-31
- Filing: Q1 FY2025 10-Q, filed 2025-05-01, accession number 0000874716-25-000062
- Page: https://plicit.ai/financials/idxx/fy2025-q1-balance-sheet
- Chart image: https://plicit.ai/charts/idxx-fy2025-q1-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2025-03-31. The chart shows assets, liabilities and equity at that date.

- **Assets**: 3,213,689,000 US dollars
- **Current assets**: 1,317,613,000 US dollars
- **Non-current assets**: 1,896,076,000 US dollars
- **Liabilities**: 1,765,676,000 US dollars
- **Current liabilities**: 1,136,213,000 US dollars
- **Non-current liabilities**: 629,463,000 US dollars
- **Equity**: 1,448,013,000 US dollars
- **Accounts receivable, net**: 527,464,000 US dollars
- **Inventories**: 395,987,000 US dollars
- **Other current assets**: 230,192,000 US dollars
- **Cash and cash equivalents**: 163,970,000 US dollars
- **Property and equipment, net**: 717,624,000 US dollars
- **Other long-term assets**: 547,559,000 US dollars
- **Goodwill**: 407,486,000 US dollars
- **Operating lease right-of-use assets**: 115,999,000 US dollars
- **Intangible assets, net**: 107,408,000 US dollars
- **Accrued liabilities**: 490,688,000 US dollars
- **Credit facility**: 319,500,000 US dollars
- **Current portion of long-term debt**: 170,929,000 US dollars
- **Accounts payable**: 120,096,000 US dollars
- **Current portion of deferred revenue**: 35,000,000 US dollars
- **Long-term debt, net of current portion**: 449,799,000 US dollars
- **Long-term operating lease liabilities, net of current portion**: 97,004,000 US dollars
- **Other long-term liabilities**: 47,731,000 US dollars
- **Long-term deferred revenue, net of current portion**: 26,819,000 US dollars
- **Deferred income tax liabilities**: 8,110,000 US dollars
- **Retained earnings**: 5,575,115,000 US dollars
- **Additional paid-in capital**: 1,695,613,000 US dollars
- **Common stock, $0.10 par value: Authorized: 120,000 shares; Issued: 107,916 shares in 2025 and 107,836 shares in 2024; Outstanding: 80,740 shares in 2025 and 81,604 shares in 2024**: 10,792,000 US dollars
- **Deferred stock units: Outstanding: 59 units in 2025 and 60 units in 2024**: 5,856,000 US dollars
- **Treasury stock, at cost: 27,176 shares in 2025 and 26,232 shares in 2024**: negative 5,749,272,000 US dollars
- **Accumulated other comprehensive loss**: negative 90,091,000 US dollars
- **Gross equity (calculated)**: 7,287,376,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.